4//SEC Filing
Kavthekar Atul 4
Accession 0001596771-19-000026
CIK 0001610092other
Filed
Mar 19, 8:00 PM ET
Accepted
Mar 20, 4:17 PM ET
Size
7.1 KB
Accession
0001596771-19-000026
Insider Transaction Report
Form 4
Kavthekar Atul
Chief Financial Officer
Transactions
- Sale
Common Stock
2019-03-19$5.84/sh−1,265$7,392→ 26,953 total - Award
Common Stock
2019-03-18+15,118→ 28,218 total
Footnotes (3)
- [F1]On March 27, 2018, Mr. Kavthekar was granted restricted stock units that were subject to the issuer's satisfaction of certain financial performance criteria. On March 18, 2019 (the "determination date"), the performance criteria was met with respect to 15,118 restricted stock units. One-third of the restricted stock units vested upon the determination date, and the remaining two-thirds will vest in two equal installments on each anniversary of the determination date, subject to continued employment.
- [F2]The sales reported in this Form 4 represent shares sold to cover the tax liability incurred incident to the delivery of shares of common stock from the previously awarded restricted stock units.
- [F3]The price represents the weighted average price of the multiple transactions reported on this line. The shares were sold at prices ranging from $5.80 to $5.8525 per share. Upon request by the SEC staff, the issuer or any securityholder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price.
Documents
Issuer
Diplomat Pharmacy, Inc.
CIK 0001610092
Entity typeother
Related Parties
1- filerCIK 0001703619
Filing Metadata
- Form type
- 4
- Filed
- Mar 19, 8:00 PM ET
- Accepted
- Mar 20, 4:17 PM ET
- Size
- 7.1 KB